The findings strongly added to the potential benefit of GLP-1RAs in reducing glaucoma risks
"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase)." Journal of Affective Disorders, 2024
Thus, clinical trials are needed to establish the benefits/risk profile in HF, considering that no properly designed, HF-specific randomised clinical trials have been completed with GLP-1 RAs in any of the HF phenotypes
Log in Womans Passage Vitanica 30 capsules $N/A (MSRP) Already have an account
While data from a RCT controls for many of the potential confounding factors, using data from non-primary endpoints requires caveats
Susane Njomo, DNP , at Prima Urgent Care offers expert care and personalized treatment for individuals seeking weight loss with semaglutide GLP-1 in Fairfax, VA